What Else Can CD39 Tell Us?

As the rate-limiting enzyme in ATP/ADP–AMP–adenosine pathway, CD39 would be a novel checkpoint inhibitor target in preventing adenosine-triggered immune-suppressive effect. In addition, CD39(hi) Tregs, but not CD25(hi) Tregs, exhibit sustained Foxp3 levels and functional abilities, indicating it cou...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Hai, Bo, Cong, Kang, Yan, Li, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479880/
https://www.ncbi.nlm.nih.gov/pubmed/28690614
http://dx.doi.org/10.3389/fimmu.2017.00727

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479880/
https://www.ncbi.nlm.nih.gov/pubmed/28690614
http://dx.doi.org/10.3389/fimmu.2017.00727

Ejemplares similares